247 results on '"Idel, Christian"'
Search Results
2. Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11
3. Dynamic microscopic optical coherence tomography to visualize morphological and functional micro-anatomy of the airways
4. Deglycosylation of pathological specimens alters performance of diagnostic PDL1 antibodies
5. Combining CD3 density and PD-L1 expression into one prognostic factor identifies patients with an exceptional prognosis
6. Einschränkung der prognostischen Relevanz von HPV bei Patienten mit Oropharynxkarzinomen bei hohem Noxenkosum
7. Intra-tumoral and peripheral PD-1/PD-L1 expression correlation in head and neck cancer
8. DNA methylation-based classification of sinonasal tumors
9. Different Influence Pattern of Conventional and Alternative Sources of Smoking on Adhesion Molecules and Cytokine Secretion in THP-1 Monocytes
10. 1,8-Cineol Attenuates Checkpoint Molecule PDL-1 and Adhesion Molecule CX3CR1 in Circulating Monocytes in Otitis Media Patients
11. Correlation of Intra-tumoral and Peripheral PD-1/PD-L1 Immunity in Head and Neck Cancer
12. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response
13. Correction to: Deglycosylation of pathological specimens alters performance of diagnostic PDL1 antibodies
14. Salvage High-Dose-Rate Interventional Radiotherapy (Brachytherapy) Combined with Surgery for Regionally Relapsed Head and Neck Cancers
15. Demographics and access to head and neck cancer care in rural areas compared to urban areas in Germany
16. 855: Salvage HDR Interventional Radiotherapy (Brachytherapy) for Recurrent Head and Neck Cancers
17. Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
18. First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m2 Cisplatin for Locally Advanced Head and Neck Cancer
19. Differential Effects of Anti-PD-1/PD-L1 Checkpoint Inhibitors on Adhesion Molecules and Cytokine Secretion by THP-1 Monocytes
20. Emotional Distress in Head-and-neck Cancer Patients Scheduled for Chemoradiation or Radiotherapy Alone
21. Plasma‑derived CD16 exosomes and peripheral blood monocytes as correlating biomarkers in head and neck cancer
22. Data from Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer
23. Supplementary Methods, Figure Legend from Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer
24. Supplementary Figures 1 - 3 from Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer
25. BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
26. In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation
27. Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern Germany.
28. Supplementary Figure from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
29. Supplementary Data from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
30. Supplementary Table from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
31. Supplementary Data from Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation
32. TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
33. Evaluation of the Impact of Smoking and Alcohol Consumption on Toxicity and Outcomes of Chemoradiation for Head and Neck Cancer
34. BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
35. Tumor-associated fibroblasts predominantly come from local and not circulating precursors
36. A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck Cancer.
37. Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck Cancer
38. First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m 2 Cisplatin for Locally Advanced Head and Neck Cancer.
39. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer
40. TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
41. Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation
42. Increased Abundances of CD16+ Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4+ T Cell Disturbances in Oropharyngeal Cancer
43. Dynamic microscopic optical coherence tomography to visualize the morphological and functional micro-anatomy of the airways
44. Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma
45. Complete response under pembrolizumab therapy
46. Smoking-, Alcohol-, and Age-Related Alterations of Blood Monocyte Subsets and Circulating CD4/CD8 T Cells in Head and Neck Cancer
47. Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
48. CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell Cancer
49. Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas
50. Delta-Like Protein 3 Expression in Paired Chemonaive and Chemorelapsed Small Cell Lung Cancer Samples
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.